Thomas Reinheckel received his doctoral degree in 1997 after medical training at the German Universities in Magdeburg and Berlin as well as at the Albert-Einstein Medical College, N.Y., USA. Abroad pre- and postdoctoral training in biochemistry and tumour biology was at the Albany Medical College, Albany, N.Y. and the UCSF Cancer Center, San Francisco. Since 2002 Dr Reinheckel heads the “Protease Group” at the Department of Molecular Medicine and Cell Research at the Albert Ludwigs University Freiburg, Germany. He obtained the “Habilitation” degree in 2007 and a full professorship from the University of Freiburg in 2013. His work is focused on elucidating in vivo functions of proteolytic enzymes in mouse models concerning tumour biology, innate immunity, and cardiac diseases.